Consumer Staples Select Sector SPDR Fund (XLP)
- Previous Close
75.15 - Open
75.27 - Bid 75.36 x 3100
- Ask 75.37 x 1300
- Day's Range
75.02 - 75.42 - 52 Week Range
65.18 - 77.82 - Volume
7,688,971 - Avg. Volume
12,936,353 - Net Assets 15.65B
- NAV 75.13
- PE Ratio (TTM) 25.70
- Yield 2.75%
- YTD Daily Total Return 5.10%
- Beta (5Y Monthly) 0.58
- Expense Ratio (net) 0.09%
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
SPDR State Street Global Advisors
Fund Family
Consumer Defensive
Fund Category
15.65B
Net Assets
1998-12-16
Inception Date
Performance Overview: XLP
Trailing returns as of 4/22/2024. Category is Consumer Defensive.
People Also Watch
Holdings: XLP
Top 10 Holdings (68.96% of Total Assets)
Sector Weightings
Recent News: XLP
Research Reports: XLP
Analyst Report: ASML Holding NV
Netherlands-based ASML Holdings N.V. provides advanced semiconductor capital equipment solutions. ASML manufactures ultraviolet lithography systems critical to the production of integrated circuits. The company, based in Europe's top technology hub near Eindhoven, has operations in Europe, the Americas, and Asia, and employs 33,000 people. The company supplies both primary semiconductor companies such as Intel and Samsung as well as merchant foundry companies such as Taiwan Semiconductor. Together with its partners, ASML is driving the development of more affordable, more powerful, and more energy-efficient chips and devices.
RatingPrice TargetAnalyst Report: Taiwan Semiconductor Manufacturing Company Limited
Taiwan Semiconductor Manufacturing Co. is the world's largest dedicated chip foundry, with almost 60% market share. TSMC was founded in 1987 as a joint venture of Philips, the government of Taiwan, and private investors. It went public as an ADR in the U.S. in 1997. TSMC's scale and high-quality technology allow the firm to generate solid operating margins, even in the highly competitive foundry business. Furthermore, the shift to the fabless business model has created tailwinds for TSMC. The foundry leader has an illustrious customer base, including Apple, AMD, and Nvidia, that looks to apply cutting-edge process technologies to its semiconductor designs. TSMC employs more than 73,000 people.
RatingPrice TargetAnalyst Report: Meta Platforms, Inc.
Meta is the world’s largest online social network, with nearly 4 billion family of apps monthly active users. Users engage with each other in different ways, exchanging messages and sharing news events, photos, and videos. The firm’s ecosystem consists mainly of the Facebook app, Instagram, Messenger, WhatsApp, and many features surrounding these products. Users can access Facebook on mobile devices and desktops. Advertising revenue represents more than 90% of the firm’s total revenue, with more than 45% coming from the U.S. and Canada and over 20% from Europe.
RatingPrice TargetAnalyst Report: Biogen Inc.
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel multiple sclerosis drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is copromoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with Sobi) were spun off as part of Bioverativ in 2017. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (post-partum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology-related fields.
RatingPrice Target